DIC, VTE, Bleeding, and Thrombotic Emergencies

DIC, VTE, Bleeding, and Thrombotic Emergencies

Cancer creates a prothrombotic state, yet many treatments simultaneously raise bleeding risk. Tumor cells, inflammatory cytokines, immobility, surgery, central venous catheters, hormonal and antiangiogenic agents (e.g., bevacizumab), thrombocytopenia, liver dysfunction, and infection all contribute. The RN's framing question is: is this patient bleeding, clotting, or both at once?

Disseminated Intravascular Coagulation

Disseminated intravascular coagulation (DIC) is systemic activation of coagulation that consumes platelets and clotting factors while forming microvascular thrombi - paradoxically producing both bleeding and clotting. It accompanies sepsis, acute promyelocytic leukemia (APL), advanced malignancy, massive tissue injury, and transfusion reactions. Findings include petechiae, ecchymoses, mucosal bleeding, hematuria, melena, oozing from IV and line sites, dyspnea, renal dysfunction, confusion, and limb ischemia.

Nursing actions: frequent vitals, head-to-toe bleeding assessment, neuro checks, intake and output, line-site checks, and rapid reporting of abnormal labs or active bleeding. Treatment targets the underlying cause and replaces components - fresh frozen plasma for factors, cryoprecipitate for fibrinogen, and platelets - with heparin only in selected thrombosis-predominant cases. Avoid unnecessary venipunctures and rectal procedures.

Venous Thromboembolism

Venous thromboembolism (VTE) - deep vein thrombosis (DVT) and pulmonary embolism (PE) - is one of the most common and lethal complications of cancer. DVT presents with unilateral leg swelling, pain, warmth, erythema, or catheter-associated arm swelling. PE presents with sudden dyspnea, pleuritic chest pain, tachycardia, hypoxia, cough, hemoptysis, syncope, or shock.

Do not massage a painful, swollen limb - you can dislodge a clot. Assess pulses, color, temperature, edema, oxygen saturation, and chest symptoms, and escalate immediately for suspected PE. A high-yield treatment point: cancer-associated thrombosis is preferentially anticoagulated with low-molecular-weight heparin (e.g., enoxaparin) or a direct oral anticoagulant (DOAC) rather than warfarin, because warfarin is less effective and harder to control around chemotherapy, nausea, and procedures.

Bleeding Emergencies and Platelet Thresholds

Bleeding risk climbs with thrombocytopenia, anticoagulants, liver dysfunction, DIC, and mucositis. Memorize the platelet thresholds:

Bleeding precautions: avoid intramuscular injections, use a soft toothbrush and electric razor, no rectal suppositories or enemas, apply pressure to puncture sites, and avoid aspirin and NSAIDs. Urgent signs include hematemesis, melena, large-volume bleeding, severe headache, focal neurologic deficit, hypotension, or syncope - intracranial hemorrhage can present as headache, vomiting, seizure, or mental status change.

Balancing Bleeding and Clotting Risk

The defining oncology challenge is the patient who must be anticoagulated for a clot yet also has thrombocytopenia, brain metastases, recent surgery, or active bleeding. The RN should not independently hold or restart anticoagulants outside policy, but must make the competing risk visible immediately: report the platelet count, hemoglobin trend, renal function (which affects enoxaparin dosing), any active bleeding, falls or head strikes, planned procedures, and the current anticoagulant dose and last administration time. For suspected stroke, limb ischemia, massive PE, or intracranial hemorrhage, activate emergency pathways at once.

Anticoagulant and Bleeding Education

Teach patients why anticoagulation matters, how to take it, what to do for a missed dose, and which signs demand urgent care: black or tarry stools, vomiting blood, severe headache, a fall with head strike, unusual bruising, persistent nosebleeds, pink or red urine, heavy vaginal bleeding, chest pain, dyspnea, or unilateral limb swelling. Reinforce both sides of the balance - do not skip anticoagulants without direction, and do not ignore bleeding or head trauma.

Prevention includes mobility as tolerated, hydration when appropriate, and meticulous central-line care, while remembering that the cancer itself keeps clot risk elevated even during active treatment.

Reversal, Transfusion Thresholds, and Reassessment

Know the basics of anticoagulant reversal because the nurse must anticipate orders during major bleeding: protamine sulfate reverses heparin and partially reverses low-molecular-weight heparin, vitamin K plus prothrombin complex concentrate reverses warfarin, idarucizumab reverses dabigatran, and andexanet alfa reverses the factor Xa inhibitors apixaban and rivaroxaban. For active or major bleeding, also anticipate red-cell transfusion guided by hemoglobin and symptoms and platelet transfusion when the count is low.

Remember that an isolated thrombocytopenia does not always mean DIC - it can reflect marrow suppression, immune thrombocytopenia, or heparin-induced thrombocytopenia, which paradoxically causes clotting and requires stopping all heparin.

Reassessment is continuous in these patients. After a fluid bolus or transfusion, recheck blood pressure, heart rate, mental status, and any bleeding site; a transient improvement that fades signals ongoing blood loss. Track the hemoglobin and platelet trends, not single values, and report a rapidly falling hemoglobin even if the absolute number still looks acceptable. The recurring OCN theme is that oncology coagulopathy is a moving target - the same patient can shift from a clotting emergency to a bleeding emergency within a single shift, so the nurse keeps both risks in view and surfaces the changing picture to the team promptly.